Skip to content
Catalyst

PapersPMID:30541572

Efficacy of a nootropic spearmint extract on reactive agility: a randomized, double-blind, placebo-controlled, parallel trial.

Journal of the International Society of Sports Nutrition2018The record ↗

findings
2
compound
1
endpoints
2
no difference found
1
  1. Finding, moderate evidencelowersC-reactive protein concentration
  2. Finding, moderate evidenceno difference foundCortisol concentration
Study, every finding
RCT
Dose studied, every finding
900 mg/day (two capsules each morning with breakfast) for 90 days
  • “Differences at baseline (p = 0.03) were present for CRP; therefore, ANCOVA was utilized to identify a significant treatment x visit interaction (p = 0.049) and pairwise comparisons revealed that PSE significantly decreased CRP at Day 30 compared to PLA (p = 0.045).”
    Duration
    4 weeks
    Interests
    An author is affiliated with a producer
    Population
    Healthy, recreationally active men and women aged 18-50 years; Day 30 timepoint

What did not

  • “Comparisons between PSE and PLA were not significantly different for cortisol and IL6.”
    Duration
    3 months
    Interests
    An author is affiliated with a producer
    Population
    Healthy, recreationally active men and women aged 18-50 years; all timepoints (Days 0, 7, 30, 90)

Study record

Design
randomised controlled trial
Species
human
Population
healthy, recreationally-active men and women aged 18–50 years; proprietary spearmint extract (PSE) 900 mg/day vs placebo
Participants
142
Comparator
placebo
Duration
90 days
Endpoints measured
80